| 1 | The suitability of BV2 cells as alternative model system for… (10.14573/altex.2009.2.83) | Abstract References ORCID License | 279.80 | 627 |
| 2 | Serum-free cell culture: the serum-free media interactive on… (10.14573/altex.2010.1.53) | Abstract References ORCID License | 243.62 | 272 |
| 3 | Fetal bovine serum (FBS): Past – present – future (10.14573/altex.1705101) | Abstract References ORCID License | 243.14 | 269 |
| 4 | A human brain microphysiological system derived from induced… (10.14573/altex.1609122) | Abstract References ORCID License | 231.18 | 204 |
| 5 | The US Federal Tox21 Program: A strategic and operational pl… (10.14573/altex.1803011) | Abstract References ORCID License | 229.67 | 197 |
| 6 | Pancreatic beta cell lines and their applications in diabete… (10.14573/altex.2010.2.105) | Abstract References ORCID License | 229.23 | 195 |
| 7 | Metabolomics in toxicology and preclinical research (10.14573/altex.2013.2.209) | Abstract References ORCID License | 224.30 | 174 |
| 8 | Re-evaluation of animal numbers and costs for in vivo tests… (10.14573/altex.2009.3.187) | Abstract References ORCID License | 222.53 | 167 |
| 9 | Alternatives to the use of fetal bovine serum: human platele… (10.14573/altex.2011.4.305) | Abstract References ORCID License | 222.53 | 167 |
| 10 | Toward Good Read-Across Practice (GRAP) guidance (10.14573/altex.1601251) | Abstract References ORCID License | 219.87 | 157 |
| 11 | A roadmap for the development of alternative (non-animal) me… (10.14573/altex.2012.1.003) | Abstract References ORCID License | 219.03 | 154 |
| 12 | Recommendation on test readiness criteria for new approach m… (10.14573/altex.1712081) | Abstract References ORCID License | 216.73 | 146 |
| 13 | Look back in anger – what clinical studies tell us about pre… (10.14573/altex.2013.3.275) | Abstract References ORCID License | 215.84 | 143 |
| 14 | Animal testing and its alternatives – the most important omi… (10.14573/altex.1807041) | Abstract References ORCID License | 214.30 | 138 |
| 15 | State-of-the-art of 3D cultures (organs-on-a-chip) in safety… (10.14573/altex1406111) | Abstract References ORCID License | 212.06 | 131 |
| 16 | Perspectives on validation of high-throughput assays support… (10.14573/altex.2013.1.051) | Abstract References ORCID License | 204.92 | 111 |
| 17 | Integrated testing strategies for safety assessments (10.14573/altex.2013.1.003) | Abstract References ORCID License | 204.53 | 110 |
| 18 | Non-animal models of epithelial barriers (skin, intestine an… (10.14573/altex.1510051) | Abstract References ORCID License | 204.14 | 109 |
| 19 | Consensus report on the future of animal-free systemic toxic… (10.14573/altex.1406091) | Abstract References ORCID License | 202.53 | 105 |
| 20 | Integrated testing strategies (ITS) for safety assessment (10.14573/altex.1411011) | Abstract References ORCID License | 202.53 | 105 |
| 21 | Evidence-based absorption, distribution, metabolism, excreti… (10.14573/altex.1610101) | Abstract References ORCID License | 197.77 | 94 |
| 22 | Advancing the science of developmental neurotoxicity (DNT):… (10.14573/altex.2012.2.202) | Abstract References ORCID License | 197.77 | 94 |
| 23 | Read-across approaches - misconceptions, promises and challe… (10.14573/altex.1410071) | Abstract References ORCID License | 197.31 | 93 |
| 24 | Biology-inspired microphysiological systems to advance medic… (10.14573/altex.2001241) | Abstract References ORCID License | 196.85 | 92 |
| 25 | Animal models of Alzheimer disease: historical pitfalls and… (10.14573/altex.1310071) | Abstract References ORCID License | 196.38 | 91 |
| 26 | Advanced Good Cell Culture Practice for human primary, stem… (10.14573/altex.1710081) | Abstract References ORCID License | 195.90 | 90 |
| 27 | From pathways to people: applying the adverse outcome pathwa… (10.14573/altex.2013.4.473) | Abstract References ORCID License | 194.45 | 87 |
| 28 | On mapping the human toxome (10.14573/altex.2011.2.083) | Abstract References ORCID License | 192.43 | 83 |
| 29 | Probabilistic risk assessment – the keystone for the future… (10.14573/altex.2201081) | Abstract References ORCID License | 190.85 | 80 |
| 30 | The dawning of a new age of toxicology (10.14573/altex.2008.2.103) | Abstract References ORCID License | 190.31 | 79 |
| 31 | Biology-inspired microphysiological system approaches to sol… (10.14573/altex.1603161) | Abstract References ORCID License | 189.76 | 78 |
| 32 | OECD/EFSA workshop on developmental neurotoxicity (DNT): The… (10.14573/altex.1701171) | Abstract References ORCID License | 189.21 | 77 |
| 33 | Alternatives to animal experimentation in basic research (10.14573/altex.2004.suppl.3) | Abstract References ORCID License | 188.65 | 76 |
| 34 | Co-culture of human alveolar epithelial (hAELVi) and macroph… (10.14573/altex.1607191) | Abstract References ORCID License | 186.33 | 72 |
| 35 | Supporting read-across using biological data (10.14573/altex.1601252) | Abstract References ORCID License | 185.73 | 71 |
| 36 | Toxicity testing in the 21st century beyond environmental ch… (10.14573/altex.1506201) | Abstract References ORCID License | 185.13 | 70 |
| 37 | Systems toxicology (10.14573/altex.2012.2.119) | Abstract References ORCID License | 185.13 | 70 |
| 38 | Comparative analysis of the revised Directive 2010/63/EU for… (10.14573/altex.2010.4.285) | Abstract References ORCID License | 184.51 | 69 |
| 39 | Food for Thought … Mechanistic Validation (10.14573/altex.2013.2.119) | Abstract References ORCID License | 183.88 | 68 |
| 40 | Integrating non-animal test information into an adaptive tes… (10.14573/altex.2011.3.211) | Abstract References ORCID License | 181.95 | 65 |
| 41 | Of rodents and men: Species-specific glucose regulation and… (10.14573/1309231) | Abstract References ORCID License | 181.29 | 64 |
| 42 | Making big sense from big data in toxicology by read-across (10.14573/altex.1603091) | Abstract References ORCID License | 181.29 | 64 |
| 43 | The use of biomarkers of toxicity for integrating in vitro h… (10.14573/altex.2012.4.411) | Abstract References ORCID License | 181.29 | 64 |
| 44 | Generation of genetically-modified human differentiated cell… (10.14573/altex.2013.4.427) | Abstract References ORCID License | 181.29 | 64 |
| 45 | The exposome – a new approach for risk assessment (10.14573/altex.2001051) | Abstract References ORCID License | 180.62 | 63 |
| 46 | Pathways of Toxicity (10.14573/altex.1309261) | Abstract References ORCID License | 179.93 | 62 |
| 47 | Food for thought … on in silico methods in toxicology (10.14573/altex.2009.3.155) | Abstract References ORCID License | 177.82 | 59 |
| 48 | Current standing and future prospects for the technologies p… (10.14573/altex.2011.1.017) | Abstract References ORCID License | 177.82 | 59 |
| 49 | Use of high-throughput in vitro toxicity screening data in c… (10.14573/altex.1703231) | Abstract References ORCID License | 177.09 | 58 |
| 50 | ToxAIcology - The evolving role of artificial intelligence i… (10.14573/altex.2309191) | Abstract References ORCID License | 177.09 | 58 |